| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
| Recent developments in the healthcare sector highlight significant advancements, especially with innovation in technology and regulatory approvals. The sector is witnessing notable growth driven by partnerships in drug development and a rising emphasis on treatment for aging populations. However, ongoing patent litigations and economic uncertainties contribute to challenges in stock market performance within this area. Overall, the combination of positive earnings and innovative drug solutions offers a balanced outlook. The price action of Health Care (XLV) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The trend sentiment at -0.9 is bearish. The market sentiment at 0.5 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for XLV since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for Health Care sector is at 0.7, and the negative at -0.2 on 2026-03-09. The forces of Sentiment towards Fundamentals (1.7), Market Risk Appetite (1.1), Price Level Sentiment (0.5), Valuation Sentiment (0.5), and Option Sentiment (0.3) will drive up the price. The forces of Broad Market Trend (-0.4), and Sector Price Trend (-0.9) will drive down the price. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on XLV trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice Sector Rotation Notification
| XLV | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-09 | 2%(1.4%) | 154.29 | 1.08% | 12 | 0.98% | -0.25% | -0.9 | 0.3 | 0.5% | 0.5 | Wait | 50% | 1.7 | 5.6 |
| 2026-03-08 | 1%(1.4%) | -1.4 | -0.2 | 1.7 | 2.8 | |||||||||
| 2026-03-07 | 2%(1.3%) | -1.4 | -0.1 | 1.8 | 1.8 | |||||||||
| 2026-03-06 | 1%(1%) | 152.8 | 1.03% | -16 | -0.74% | -0.25% | -1.4 | 0 | 1.4% | 0.2 | Wait | 50% | 1.8 | -0.9 |
| 2026-03-05 | 1%(1%) | 153.94 | 0.88% | -8 | -1.98% | -0.19% | -0.7 | -0.4 | 1.1% | 0.9 | Wait | 50% | 2.1 | 6.1 |
| 2026-03-04 | 2%(1%) | 157.05 | 0.75% | 47 | 0.17% | -0.06% | -0.1 | -0.1 | 0.6% | 0.7 | Short | 55% | 2.1 | 5.2 |
| 2026-03-03 | 1%(0.9%) | 156.78 | 0.87% | 46 | -1.11% | -0.06% | -0.3 | -0.1 | 0.9% | 0.5 | Short | 55% | 2 | 2.3 |
| 2026-03-02 | 2%(1%) | 158.54 | 0.88% | 78 | -1.02% | 0.06% | 0.2 | 0 | 0.6% | 0.8 | Long | 55% | 2.1 | 3.1 |
| 2026-03-01 | 0%(1.1%) | 0.9 | 0.6 | 2.3 | -0.5 | |||||||||
| 2026-02-28 | 0%(1.1%) | 0.9 | 0.6 | 2.3 | -0.5 | |||||||||
| Wait is the preferred trading strategy with 50% chance of being right. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| Analysis | ||
| ● Health Care Sector Check-Up: What Analysts Are Saying Right Now Mon. Sep 29, 2025 | ||
| Market News | ||
| 1 (8) Uber expands Women Preferences, Hims & Hers stock skyrockets Yahoo Finance Senior Reporter Brooke DiPalma and Market Domination host Josh Lipton discuss some of Monday's top trending stories. Ticketmaster parent company Live Nation (LYV) reached a settlement in a monopolization lawsuit with the US Department of Justice (DOJ). Hims & Hers (HIMS) stock skyrocketed on Monday after a big win: the company struck a deal with Novo Nordisk (NVO) to bring GLP-1 drugs Ozempic and Wegovy onto its platform. Uber's (UBER) "Women Preferences" feature is expanding nationwide. To watch more expert insights and analysis on the latest market action, check out more Market Domination. (https://finance.yahoo.com/) Mon. Mar 9, 2026 | ||
| 2 (8) Hims & Hers stock skyrockets 40% as Novo Nordisk ends feud, agrees to sell Ozempic and Wegovy on platform Hims & Hers shares jumped more than 50% in premarket trade on Monday after ending a dispute with Novo Nordisk by striking a partnership with the Danish drug giant. (https://www.marketwatch.com/) Mon. Mar 9, 2026 | ||
| 3 (8) Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy? Hims & Hers stock traded more than 40% higher after the deal was announced. (https://www.fool.com/) Mon. Mar 9, 2026 | ||
| 4 (5) Hims partners with Novo Nordisk, Live Nation settles antitrust suit Market Catalysts host Julie Hyman takes a look at some of Monday morning's trending tickers and stories, including Hims & Hers Health (HIMS) to start selling Novo Nordisk's (NVO) GLP-1 weight-loss drugs on its platform, Live Nation (LYV) settling its antitrust lawsuit with the Department of Justice (DOJ), and cruise line stocks taking a hit from escalations in the Iran war. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts. (https://finance.yahoo.com/) Mon. Mar 9, 2026 | ||
| 5 (8) Hims & Hers stock surges as Novo Nordisk says it will distribute weight-loss drugs on platform Hims stock surged more than 40% Monday morning on news that Novo Nordisk will distribute its weight-loss drugs through the Hims platform. (https://finance.yahoo.com/) Mon. Mar 9, 2026 | ||
| 6 (2) Hims & Hers Erupts In Epic Squeeze As Novo Nordisk Ends GLP-1 Feud ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero (https://www.zerohedge.com/) Mon. Mar 9, 2026 | ||
| 7 (0) Hims & Hers Health Inc. Complete Hims & Hers Health Inc. stock information by Barron's. View real-time HIMS stock price and news, along with industry-best analysis. (https://www.barrons.com/) Mon. Mar 9, 2026 | ||
| 8 (8) Hims & Hers Stock Soars 53%. It’s Struck a Truce With Novo Nordisk, Report Says. Novo Nordisk has agreed to sell its weight-loss injectables and its Wegovy pill on Hims’ platform. (https://www.barrons.com/) Mon. Mar 9, 2026 | ||
| 9 (8) Hims & Hers Stock Soars 53%. It’s Struck a Truce With Novo Nordisk, Report Says. Novo has agreed to sell its weight-loss drugs on Hims’ platform, according to a report. (https://www.barrons.com/) Mon. Mar 9, 2026 | ||
| 10 (6) Novo Drops Hims & Hers Lawsuit and Will Sell Wegovy on Site Novo Nordisk A/S and Hims & Hers Health Inc. will work together to sell obesity drugs, a sudden reversal after more than eight months of acrimony that culminated in a legal battle. (https://www.bloomberg.com/) Mon. Mar 9, 2026 | ||
| 11 (8) Hims & Hers shares surge 50% after Novo Nordisk drops patent infringement case over compounded weight loss drugs Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines. (https://www.cnbc.com/) Mon. Mar 9, 2026 | ||
| 12 (9) Hims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars Hims & Hers stock jumps 49% premarket after ending lawsuit with Novo Nordisk and securing weight-loss drug partnership. (https://www.benzinga.com/) Mon. Mar 9, 2026 | ||
| 13 (-5) Roche's Breast Cancer Drug Falls Short In Phase 3 Study Roche's phase 3 persevERA breast cancer trial misses its primary goal, though numerical gains were seen. See the full clinical breakdown. (https://www.benzinga.com/) Mon. Mar 9, 2026 | ||
| 14 (7) Universal Health strikes $835 million Talkspace deal in mental health push March 9 () - Hospital operator Universal Health Services said on Monday it would acquire virtual healthcare provider Talkspace in a deal valued at $835 million, amid rising demand for behavioral health services. Universal Health Services will pay $5. (https://finance.yahoo.com/) Mon. Mar 9, 2026 | ||
| 15 (7) Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit COPENHAGEN, March 9 (Reuters) - Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic drugs through U.S. telehealth company Hims & Hers' platform, the Danish drugmaker said on Monday, (https://finance.yahoo.com/) Mon. Mar 9, 2026 | ||
| 16 (8) Hims & Hers stock rockets on end to Novo Nordisk weight-loss drug dispute Hims & Hers shares jumped more than 50% in premarket trade on Monday after ending a dispute with Novo Nordisk by striking a partnership with the Danish drug giant. (https://www.marketwatch.com/) Mon. Mar 9, 2026 | ||
| 17 (8) Hims & Hers stock rockets on end to Novo Nordisk weight-loss drug dispute Hims & Hers shares jumped more than 50% in premarket trade on Monday after ending a dispute with Novo Nordisk by striking a partnership with the Danish drug giant. (https://www.marketwatch.com/) Mon. Mar 9, 2026 | ||
| 18 (8) The Aging of America Could Make HCA Healthcare a Long-Term Winner As healthcare companies anticipate a massive uptick in demand from an aging population, HCA Healthcare may be positioning itself to stand out. (https://www.marketbeat.com/) Sun. Mar 8, 2026 | ||
| 19 (0) Dave Ramsey shares key statement on Medicare The bestselling personal finance author sends a strong message on the federal health care program for retired Americans. (https://www.thestreet.com/) Sun. Mar 8, 2026 | ||
| 20 (2) 1 Dividend Stock to Buy Hand Over Fist and 1 to Avoid Eli Lilly may be the GLP-1 leader, but its valuation is stretched. (https://www.fool.com/) Sun. Mar 8, 2026 | ||
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA